News Rising UK drugs bill raises fears of price controls Higher than expected growth in the branded medicines bill has caused the UK government to consider price cuts.
News A vote of no confidence in UK's pricing system The new PPRS is not good news for all pharma companies, concludes industry audience
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
